Knowledge Means Power

Rezulin (troglitazone)

Rezulin is a drug manufactured by Warner-Lambert/Parke-Davis Company used to treat Type 2 Diabetes. Rezulin (troglitazone) was banned in England in December 1997. On March 22, 2000, the manufacturer announced that it was discontinuing the sale of Rezulin

in the United States after the Federal Drug Administration determined that it was too dangerous for use. Some patients had experienced severe liver problems including liver failure and even death.

Before the ban, sales of Rezulin produced $1.8 billion in revenues.

Stats of known effects of Rezulin:

• 7 liver transplant survivors
• 10 recoveries without a liver transplant
• 10 people continuing to suffer from liver failure
• 63 deaths
Posted: Aug 30 2009, 03:39 PM by digitalangel | with no comments
Add to Bloglines Add to Del.icio.us Add to digg Add to Facebook Add to Google Bookmarks Add to Newsvine Add to reddit Add to Stumble Upon Add to Shoutwire Add to Squidoo Add to Technorati Add to Yahoo My Web